Profile
Andrew Sinclair Dunlop is the founder of Epidarex Capital Partners LLC, founded in 2010, where the title held is Managing Partner.
Current jobs include Chairman at Inspiring Scotland since 2015, Director at Clyde Biosciences Ltd. since 2015, Director at Lario Therapeutics Ltd. since 2023, Director at SIRAKOSS Ltd., Director at Mironid Ltd., and Trustee at Reform Scotland Ltd. Former jobs include Director at MaxCyte, Inc., Director at MediQuest Therapeutics, Inc., Non-Executive Director at enGene, Inc. from 2008 to 2011, Director at MASA, Inc., Director at Theolytics Ltd. from 2021 to 2023, Independent Director at Apellis Pharmaceuticals, Inc. from 2010 to 2026, Director at Edinburgh Molecular Imaging Ltd. from 2014 to 2022, Director at Potentia Pharmaceuticals, Inc., Associate at New Vantage Group LLC, Managing Partner at MASA Life Science Ventures from 2005 to 2015, and Business & Economics Analyst at Center for Strategic & International Studies, Inc. Education includes graduation from the University of Glasgow in 1994, graduation from Maxwell School of Syracuse University in 1995, and an MBA from Columbia Business School in 2000.
Andrew Dunlop active positions
| Companies | Position | Start |
|---|---|---|
Reform Scotland Ltd.
Reform Scotland Ltd. Miscellaneous Commercial ServicesCommercial Services Operates political organization | Director/Board Member | - |
Inspiring Scotland
Inspiring Scotland Miscellaneous Commercial ServicesCommercial Services Engages in dealing and solving social problems for its people and communities | Chairman | 01/01/2015 |
Mironid Ltd.
Mironid Ltd. Pharmaceuticals: MajorHealth Technology Develops proprietary drug candidate molecules | Director/Board Member | - |
Epidarex Capital Partners LLC
Epidarex Capital Partners LLC Investment ManagersFinance Epidarex Capital invests in companies located in the United States and United Kingdom. The firm targets companies operating in the fields of life science including biotechnology & pharmaceuticals, medical devices & health tech sectors. It provides financing for seed and early stage capital requirements and also makes follow on investments. | Founder | 01/01/2010 |
SIRAKOSS Ltd.
SIRAKOSS Ltd. Medical SpecialtiesHealth Technology Manufactures medical devices | Director/Board Member | - |
Clyde Biosciences Ltd.
Clyde Biosciences Ltd. Miscellaneous Commercial ServicesCommercial Services Provides developmental drug testing services | Director/Board Member | 01/01/2015 |
Former positions of Andrew Dunlop
| Companies | Position | End |
|---|---|---|
| APELLIS PHARMACEUTICALS, INC. | Director/Board Member | 14/05/2026 |
Theolytics Ltd.
Theolytics Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Director/Board Member | 01/01/2023 |
Edinburgh Molecular Imaging Ltd.
Edinburgh Molecular Imaging Ltd. Medical SpecialtiesHealth Technology Develops optical molecular imaging technology, which includes optical imaging, cancer imaging and lung imaging | Director/Board Member | 01/01/2022 |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░ ░░░░░░░ ░░░░░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
Training of Andrew Dunlop
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 20 |
|---|---|
MaxCyte, Inc.
MaxCyte, Inc. BiotechnologyHealth Technology Specializes in cell modification technologies to enable the discovery, development, manufacturing, and delivery of therapeutic products | Health Technology |
Potentia Pharmaceuticals, Inc.
Potentia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics and drug delivery technologies | Health Technology |
MediQuest Therapeutics, Inc.
MediQuest Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of inflammatory skin diseases and conditions | Health Technology |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which develops non-viral gene therapies | Health Technology |
Apellis Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics and drug delivery technologies to address chronic inflammatory diseases | Health Technology |
University of Glasgow
University of Glasgow Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New Vantage Group LLC
New Vantage Group LLC Investment ManagersFinance New Vantage Group seeks investment in companies located in the United States primarily in Washington, DC. The firm focuses on board range of sectors and industries. It provides financing for early-stage transactions. | Finance |
MASA, Inc.
MASA, Inc. Miscellaneous Commercial ServicesCommercial Services MASA focuses on private equity investments in a variety of sectors including biotechnology, consumer products, energy, environmental technology, financial services, healthcare, infrastructure, new media, real estate, sports/recreation, telecommunications, transportation and nanotechnology. They invest in the US, Europe, Latin America, Israel, Japan, Russia, South Korea and West Africa. Their investments are across the capital structure including seed stage, mezzanine financings and buyouts. | Commercial Services |
MASA Life Science Ventures
MASA Life Science Ventures Investment ManagersFinance MASA Life Science Ventures invests in early-stage companies located in the United States, Canada, Europe and Israel. The firm targets companies operating in the fields of bio-therapeutics, medical devices, medical diagnostics, healthcare and bio-IT. | Finance |
Center for Strategic & International Studies, Inc.
Center for Strategic & International Studies, Inc. Miscellaneous Commercial ServicesCommercial Services Provides strategic insights & policy solutions to decision makers in government, international institutions, the private sector and civil society | Commercial Services |
Maxwell School of Syracuse University
Maxwell School of Syracuse University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Reform Scotland Ltd.
Reform Scotland Ltd. Miscellaneous Commercial ServicesCommercial Services Operates political organization | Commercial Services |
Inspiring Scotland
Inspiring Scotland Miscellaneous Commercial ServicesCommercial Services Engages in dealing and solving social problems for its people and communities | Commercial Services |
Epidarex Capital Partners LLC
Epidarex Capital Partners LLC Investment ManagersFinance Epidarex Capital invests in companies located in the United States and United Kingdom. The firm targets companies operating in the fields of life science including biotechnology & pharmaceuticals, medical devices & health tech sectors. It provides financing for seed and early stage capital requirements and also makes follow on investments. | Finance |
Columbia Business School
Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SIRAKOSS Ltd.
SIRAKOSS Ltd. Medical SpecialtiesHealth Technology Manufactures medical devices | Health Technology |
Clyde Biosciences Ltd.
Clyde Biosciences Ltd. Miscellaneous Commercial ServicesCommercial Services Provides developmental drug testing services | Commercial Services |
Mironid Ltd.
Mironid Ltd. Pharmaceuticals: MajorHealth Technology Develops proprietary drug candidate molecules | Health Technology |
Edinburgh Molecular Imaging Ltd.
Edinburgh Molecular Imaging Ltd. Medical SpecialtiesHealth Technology Develops optical molecular imaging technology, which includes optical imaging, cancer imaging and lung imaging | Health Technology |
Theolytics Ltd.
Theolytics Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Health Technology |
- Stock Market
- Insiders
- Andrew Dunlop
















